Obstructive Sleep Apnoea Clinical Trial
This study aims to investigate the role of the Mediterranean diet in obese patients with Obstructive sleep apnoea-hypopnoea syndrome.
Obstructive sleep apnoea-hypopnoea syndrome (OSAHS) is considered to be one of the most prevalent sleep-related breathing disorders, with an enormous effect on public health. Approximately 2-4% of the general adult population experiences some degree of this syndrome. This percentage increases even more with obesity, up to 20-40%, especially in individuals with an excessive body mass index (BMI) > 30 kg/m2. OSAHS is associated with significant systemic consequences, including cardiovascular morbidity and mortality, and the risk increases with the severity of the syndrome. The pathophysiology underlying the link between OSAHS and the cardiovascular system is attributed largely to systemic inflammation and oxidative stress, which are both contributors to endothelial dysfunction. The treatment modalities of OSAHS include continuous positive airway pressure (CPAP), weight loss, upper airway surgery, and medication. CPAP is the first line therapy, as a means of maintaining upper airway patency, and it is well known that this intervention reduces morbidity and mortality. In severe cases of OSAHS the weight loss strategy is essential and must accompany CPAP treatment. A growing body of evidence in OSAHS supports the beneficial role of weight reduction, induced by diet alone or in combination with exercise, leading to a reduction in apnoeas and hypopnoeas.We aim to evaluate the effect of the Mediterranean diet compared with that of a prudent diet on obese OSAHS patients who were treated with CPAP while receiving counselling to increase their physical activity. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01620554 -
Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
|
Phase 2 | |
Not yet recruiting |
NCT01985347 -
The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort Study
|
N/A | |
Completed |
NCT02967536 -
Investigating the Neuropathology of Obstructive Sleep Apnoea
|
||
Completed |
NCT02855515 -
Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea
|
N/A | |
Terminated |
NCT03127800 -
Morphine in Moderate Obstructive Sleep Apnoea
|
Phase 3 | |
Recruiting |
NCT04262986 -
A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
|
||
Completed |
NCT03145129 -
PAIR Study-PAP And IOP Relationship: Study 2
|
||
Completed |
NCT06376305 -
EndoBarrier in Obstructive Sleep Apnoea Study
|
N/A | |
Completed |
NCT02713152 -
Prevalence of Obstructive Sleep Apnoea in Glaucoma
|
N/A | |
Completed |
NCT01661712 -
Continuous Transcutaneous Electrical Stimulation in Sleep Apnoea
|
N/A | |
Terminated |
NCT01530451 -
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
|
Phase 3 | |
Completed |
NCT02518633 -
Obstructive Sleep Apnoea and Adipose Tissue Dysfunction
|
N/A | |
Completed |
NCT01557166 -
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALEā¢ - Sleep Apnoea
|
Phase 3 | |
Recruiting |
NCT01829854 -
To Investigate the Incidence of Obstructive Sleep Apnoea in Patient Undergoing Open Heart Surgery
|
N/A | |
Completed |
NCT01619748 -
Peripheral Vascular Function in Obstructive Sleep Apnoea
|
N/A | |
Completed |
NCT02417584 -
Efficacy of PAP Therapy on Blood Pressure
|
N/A | |
Completed |
NCT04071860 -
Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
|
||
Not yet recruiting |
NCT04607343 -
Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea
|
N/A | |
Completed |
NCT01546792 -
Lifestyle Intervention in Obstructive Sleep Apnoea
|
Phase 2/Phase 3 | |
Completed |
NCT00300599 -
Effect of Continuous Positive Airway Pressure (CPAP) on Systemic Blood Pressure, Coagulability and Carotid Intima-media Thickness in Patients With Sleep Apnea
|
N/A |